24 Feb 2021

NeuroRx’s Zyesami accelerates recovery in Covid-19 trial

NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure in critically ill Covid-19 patients. It was initially approved as…